Total thyroidectomy versus lobectomy for papillary thyroid cancer: a systematic review and meta-analysis

C Zhang, Y Li, J Li, X Chen - Medicine, 2020 - journals.lww.com
Background: This systematic review and meta-analysis collected data for evaluating the
effect of surgical extent on overall survival (OS) and recurrence-free survival (RFS) in …

Systematic review of recurrence rate after hemithyroidectomy for low-risk well-differentiated thyroid cancer

S Chan, K Karamali, A Kolodziejczyk… - European Thyroid …, 2020 - etj.bioscientifica.com
Background: Surgical extent in the management of well-differentiated thyroid cancer (DTC)
remains a recurrent subject of debate. This is especially relevant in low-risk DTC of 1–4 cm …

Active surveillance for patients with papillary thyroid microcarcinoma: a single center's experience in Korea

H Kwon, HS Oh, M Kim, S Park, MJ Jeon… - The Journal of …, 2017 - academic.oup.com
Context: Papillary thyroid microcarcinoma (PTMC) usually has an excellent prognosis.
Objective: To evaluate the three-dimensional structures of PTMCs, using serial neck …

Immune profiling identifies CD8+ T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer

Z Chen, ML Guo, YY Li, K Yan, L Li, F Shen… - Frontiers in …, 2022 - frontiersin.org
Background Thyroid tissue has a special immune microenvironment that is not well
characterized. Whether immune cells have a prognostic value in the recurrence of papillary …

Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction

GJ Xu, MA Loberg, JN Gallant, Q Sheng, SC Chen… - Cell Genomics, 2023 - cell.com
Genomic and transcriptomic analysis has furthered our understanding of many tumors. Yet,
thyroid cancer management is largely guided by staging and histology, with few molecular …

Health-related quality of life following total thyroidectomy and lobectomy for differentiated thyroid carcinoma: a systematic review

V Landry, E Siciliani, M Henry, RJ Payne - Current Oncology, 2022 - mdpi.com
Health-related quality of life (HrQoL) is a major concern for patients with differentiated
thyroid carcinoma (DTC). We aimed to systematically review the literature comparing HrQol …

Postoperative thyroid-stimulating hormone levels did not affect recurrence after thyroid lobectomy in patients with papillary thyroid cancer

MC Lee, MJ Kim, HS Choi, SW Cho… - Endocrinology and …, 2019 - synapse.koreamed.org
Background Thyroid-stimulating hormone (TSH) suppression is recommended for patients
who undergo thyroidectomy for differentiated thyroid cancer (DTC). However, the impact of …

Clinical outcomes of multifocal papillary thyroid cancer: A systematic review and meta‐analysis

L Cui, D Feng, C Zhu, Q Li, W Li… - Laryngoscope …, 2022 - Wiley Online Library
Objective Papillary thyroid cancer (PTC) is the most common endocrine malignancy with a
steadily increasing incidence. Researches have reported that tumor multifocality occurs in …

Follow-up of low risk thyroid cancer patients: can we stop follow-up after 5 years of complete remission?

L Lamartina… - European Journal of …, 2020 - academic.oup.com
Each year, the proportion of thyroid cancer patients presenting with low-risk disease is
increasing. The shift in the landscape of thyroid cancer presentation is forcing clinicians to re …

Clinicopathological significance of papillary thyroid carcinoma located in the isthmus: A meta-analysis

YS Lyu, JS Pyo, WJ Cho, SY Kim, JH Kim - World Journal of Surgery, 2021 - Springer
Background The thyroid isthmus is located directly anterior to the trachea and is covered by
the strap muscles. Several studies have suggested that papillary thyroid carcinoma (PTC) in …